Novo Nordisk

US firms usually look leaner than their European counterparts when judged by revenue per employee

The company’s shares have nearly halved since the start of the year and expects slower growth this year

Halt to hiring will apply across all markets and departments

Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years

Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk

Novo Nordisk has now lost two-thirds of its value in little over a year

Pharma companies also volatile in wake of letters from US president to 17 of them demanding lower prices

Drugmaker Novo Nordisk shares dive amid lower profits

Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come

Aviation stocks drop amid soaring jet fuel prices in Europe

Iseq index advances 0.5%, dragged higher by Ryanair and the main Irish banks

Parvus shows interest in Danish drugmaker that is hunting for new chief following share price slump

In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

‘Significant number of non-compliances’ by pharmaceutical firm behind weight loss drugs

Investor expectations, it seems, are harder to manage than blood sugar

Pharmaceutical companies stepped up blitz to push Government to back industry position, lobbying logs show

Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed

First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up

Drugmaker has seen shares halved as obesity market heats up

Industry has used trade opportunity to hand European Commission a shopping list of asks

Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments

SAP is now Europe’s most valuable public company

Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients

Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least

New regulations of pharma sector could cost jobs in Ireland, industry warned Government

Pharma companies ‘disappointed’ in Government’s stance during EU negotiations

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year

Danish obesity drug giant looking at whether its semaglutide drug can reduce cravings associated with addiction

Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately

Iseq index flat as Ryanair adds 1% despite sluggish traffic growth

Indices in Europe end last full trading week with losses as Washington again battles to stop government shutdown

Obesity drug CagriSema misses goal of 25% body weight reduction

Companies competing for leadership in fast-growing market where supply continues to be an issue

Brussels rather than the Trump White House is seen by industry as the more immediate threat to its wellbeing

European Commission has proposed reducing the period of regulatory data protection from eight years to six years

Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination

US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines

Announcement is first major investment by a US multinational following Trump victory in presidential election

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use

Strong day for banking stocks lifts Irish market, while Airbnb and Puma fall after weak outlook statements